• Extend 340B program to DSH inpatient setting and include critical access hospitals in the 340B program.
• Address the integrity of the 340B program by working to improve program oversight, administration, and compliance; recover 340B overpayments; make 340B prices available to covered entities.
• Address proposed government guidelines that would significantly restrict the use of the 340B program by narrowing the definition of “patient” under the program.
• Clarify Section 6002 of the Deficit Reduction Act of 2005 to avoid implementation by CMS mandating states to collect rebates on drugs administered by health professionals in hospital outpatient settings.
• Make efforts to ensure that 340B participants benefit from proposed increase in Medicaid rebate discount and ensure that any changes to Medicaid rebate law do not adversely impact 340B program.
• Improve the Medicare Pat D drug benefit to ensure 340B provider participation and allow contributions made by 340B pharmacies to count toward true out-of-pocket costs (TrOOP).
• Address problems in accessing IVIG and other products at federally required 340B-discounted pricing.

110th Congress

• The 340B Program Improvement and Integrity Act of 2007 (S. 1376 / H.R. 2606)
• Cosponsors (Senate / House)
• Congressman Bobby Rush's News Release on H.R. 2606
• Senator Bingaman's News Release on S. 1376
• Senator Thune's News Release on S. 1376
• SNHPA News Releases (Senate / House)
• Op-Ed in The Hill, September 11, 2007: "A Simple Step to Address Pharmaceutical Costs"
• From Drug Topics, June 18, 2007: "Bill Would Allow 340B Discounts for Inpatient "
• From United Press International, June 7, 2007: "Analysis: New Bill to Expand Drug Discount "

109th Congress

• Safety Net Inpatient Drug Affordability Act (S. 1840 / H.R. 3547)
• Cosponsors (Senate / House)
• Press Releases (Senate / House)
• Press Release for SNHPA Inpatient Pricing Report
• Pharmacy Access Improvement (PhAIm) Act (S. 2664)
• Filling the Medicare Rx. Gap Act (S. 3650)
• Healthy America Act (Sec. 332 S. 4)